Marksans Pharma Limited – NSE:MARKSANS.NS
Marksans Pharma Limited stock price today
Marksans Pharma Limited stock price monthly change
Marksans Pharma Limited stock price quarterly change
Marksans Pharma Limited stock price yearly change
Marksans Pharma Limited key metrics
Market Cap | 133.11B |
Enterprise value | 131.26B |
P/E | 38.43 |
EV/Sales | 5.51 |
EV/EBITDA | 23.68 |
Price/Sales | 5.59 |
Price/Book | 5.84 |
PEG ratio | 2.67 |
EPS | 6.93 |
Revenue | 21.77B |
EBITDA | 4.92B |
Income | 3.13B |
Revenue Q/Q | 15.23% |
Revenue Y/Y | 17.56% |
Profit margin | 14.59% |
Oper. margin | 18.02% |
Gross margin | 46.84% |
EBIT margin | 18.02% |
EBITDA margin | 22.62% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMarksans Pharma Limited stock price history
Marksans Pharma Limited stock forecast
Marksans Pharma Limited financial statements
| Jun 2023 | 5.00B | 686.58M | 13.73% |
|---|---|---|---|
| Sep 2023 | 5.31B | 835.18M | 15.72% |
| Dec 2023 | 5.86B | 832.35M | 14.2% |
| Mar 2024 | 5.60B | 782.89M | 13.98% |
| 2026 | 31.79B | 4.85B | 15.26% |
|---|
Analysts Price target
Financials & Ratios estimates
| Payout ratio | 0% |
|---|
| 2016 | 0.95% |
|---|---|
| 2017 | 0.75% |
| 2019 | 0.42% |
| 2020 | 5.19% |
| 2022 | 0.57% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 23135750000 | 4.16B | 18.01% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 26809530000 | 5.95B | 22.2% |
| Mar 2023 | 278.88M | 0 | 0 |
|---|---|---|---|
| Jun 2023 | 273.2M | 0 | 0 |
| Sep 2023 | 351.02M | 0 | 0 |
| Dec 2023 | 440.06M | 0 | 0 |
Marksans Pharma Limited alternative data
| Aug 2023 | 1,412 |
|---|---|
| Sep 2023 | 852 |
| Oct 2023 | 852 |
| Nov 2023 | 852 |
| Dec 2023 | 852 |
| Jan 2024 | 852 |
| Feb 2024 | 852 |
| Mar 2024 | 852 |
| Apr 2024 | 852 |
| May 2024 | 852 |
| Jun 2024 | 852 |
| Jul 2024 | 852 |
Marksans Pharma Limited other data
| Insider | Compensation |
|---|---|
Mr. Varddhman Vikramaditya Jain (1970) Executive & Non-Independent Director | $14,680,000 |
Mr. Mark B. Saldanha (1972) Non-Independent Executive Chairman, MD & Chief Executive Officer | $10,430,000 |
Ms. Sandra Saldanha (1971) Executive Non-Independent Director | $7,030,000 |
-
What's the price of Marksans Pharma Limited stock today?
One share of Marksans Pharma Limited stock can currently be purchased for approximately $61.8.
-
When is Marksans Pharma Limited's next earnings date?
Unfortunately, Marksans Pharma Limited's (MARKSANS.NS) next earnings date is currently unknown.
-
Does Marksans Pharma Limited pay dividends?
Yes, Marksans Pharma Limited pays dividends and its trailing 12-month yield is 0.2% with 0% payout ratio. The last Marksans Pharma Limited stock dividend of $0 was paid on 5 Sep 2025.
-
How much money does Marksans Pharma Limited make?
Marksans Pharma Limited has a market capitalization of 133.11B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 47.11% to 21.77B US dollars.
-
What is Marksans Pharma Limited's stock symbol?
Marksans Pharma Limited is traded on the NSE under the ticker symbol "MARKSANS.NS".
-
What is Marksans Pharma Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - General industry.
-
How do i buy shares of Marksans Pharma Limited?
Shares of Marksans Pharma Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Marksans Pharma Limited's key executives?
Marksans Pharma Limited's management team includes the following people:
- Mr. Varddhman Vikramaditya Jain Executive & Non-Independent Director(age: 55, pay: $14,680,000)
- Mr. Mark B. Saldanha Non-Independent Executive Chairman, MD & Chief Executive Officer(age: 53, pay: $10,430,000)
- Ms. Sandra Saldanha Executive Non-Independent Director(age: 54, pay: $7,030,000)
-
How many employees does Marksans Pharma Limited have?
As Jul 2024, Marksans Pharma Limited employs 852 workers.
-
When Marksans Pharma Limited went public?
Marksans Pharma Limited is publicly traded company for more then 23 years since IPO on 19 Jul 2002.
-
What is Marksans Pharma Limited's official website?
The official website for Marksans Pharma Limited is marksanspharma.com.
-
How can i contact Marksans Pharma Limited?
Marksans Pharma Limited can be reached via phone at +91 22 4001 2000.
Marksans Pharma Limited company profile:
Marksans Pharma Limited
marksanspharma.comNSE
1,141
Drug Manufacturers - General
Healthcare
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Mumbai, 400053
:
ISIN: INE750C01026
CUSIP: Y57686100
